Candel Therapeutics, Inc.CADLNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank83
3Y CAGR-15.6%
5Y CAGR+14.4%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-15.6%/yr
Annual compound
5Y CAGR
+14.4%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20251.00+104.9%
20240.49-45.7%
20230.90-46.0%
20221.67+171.8%
20210.62+19.9%
20200.51-18.3%
20190.63-